Loading...
XSHG
603309
Market cap568mUSD
Dec 05, Last price  
13.76CNY
1D
0.81%
1Q
-3.98%
Jan 2017
-29.32%
IPO
46.62%
Name

Well Lead Medical Co Ltd

Chart & Performance

D1W1MN
XSHG:603309 chart
P/E
18.31
P/S
2.66
EPS
0.75
Div Yield, %
3.63%
Shrs. gr., 5y
2.39%
Rev. gr., 5y
8.72%
Revenues
1.51b
+10.02%
348,235,226387,220,714437,167,108496,414,401548,871,062515,419,906629,894,884745,834,592993,812,5561,130,678,8091,118,570,9381,363,352,5541,371,925,6731,509,335,256
Net income
219m
+13.98%
47,924,93155,609,39963,585,72667,819,98091,324,89879,249,98264,557,09165,403,009121,144,863153,110,853106,093,288166,571,286192,485,118219,393,029
CFO
306m
+31.15%
44,075,92783,234,11372,853,113107,343,45181,466,12385,348,01574,343,82889,888,862178,794,590228,443,989187,283,077391,125,593233,512,282306,259,194
Dividend
May 23, 20240.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Well Lead Medical Co., Ltd. engages in the research, production, and sale of medical catheters in anaesthesia, urology, respiratory, and hemodialysis areas. It also provides drainage suction nutrition products. Its products are used in hospitals, in division operations, therapies, and emergency and clinical care areas. The company markets and sells its products in China, North America, Europe, and Japan. Well Lead Medical Co., Ltd. was founded in 2004 and is headquartered in Guangzhou, China.
IPO date
Mar 02, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT